Login to Your Account


Breakthrough to ensue?

Looking ahead to the pivotal trial in triple-negative breast cancer with IMMU-132, slated to begin this summer, Immunomedics Inc. stands as "the only game in town at the moment this far along that has an antibody that targets this [TROP-2] receptor," Chau Cheng, director of investor relations, told BioWorld Today.

more »


Our Habitat for All Things Science
WHO declares Zika an international emergency as IVD makers deliver 1st tests

PARIS – With increasing reports of neurological disorders and neonatal malformations caused by the Zika virus from 22 countries, the World Health Organization (WHO) has declared an international emergency, calling it an “extraordinary event.”

The WHO estimated there could be up to 4 million cases of Zika in the Americas in the next year, but no recommendations were made to restrict travel or trade. The WHO alert puts Zika in the same category of concern as Ebola.

READ MORE »

Opinion


Partners in Focus